Emflaza Supply Not Affected by COVID-19 Pandemic, PTC Therapeutics Says
News
The supply of Emflaza (deflazacort), a treatment for people with Duchenne muscular dystrophy (DMD), will not be affected by the COVID-19 pandemic, according to PTC Therapeutics, its developer. In ... Read more